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Human β-defensin 3 has received great interest for possible pharmaceutical applications. To characterize the biology of this
antimicrobial peptide, the mouse β-defensin 14 has been selected as a prototypical model. This report provides deﬁnite evidence
of true orthology between these defensins and reveals molecular diversity of a mammalian speciﬁc domain responsible for their
antimicrobial activity. Speciﬁcally, this analysis demonstrates that eleven amino acid residues of the antimicrobial domain have
been mutated by positive selection to confer protein niche specialization. These data support the notion that natural selection acts
asevolutionaryforcedrivingtheproliferationanddiversiﬁcationofdefensinsandintroduceanovelstrategyforthedesignofmore
eﬀective antibiotics.
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1.Introduction
A variety of antimicrobial peptides are produced by animals
and plants as elemental components of their defense system
to combat infectious microbes, including bacteria, fungi,
viruses, and protozoa [1]. Among this antimicrobial protein
repertoire, defensins are the most eﬃcient and ancient
components of host defense [2]. Recent analyses indicated
that the cysteine-stabilized α-helical and β-sheet protein fold
characteristic of the defensin family originated before the
emergence of eukaryotes [3]. Even though defensins have an
ancient origin, the majority of microbial pathogens have not
developed highly eﬀective mechanisms of resistance against
these antimicrobial compounds [1, 2]. Antimicrobial resis-
tance to defensins have been observed in some pathogens
[4]; however, it has been proposed that the production
of antimicrobial peptides and mechanisms of resistance
have coevolved at similar rate, generating a niche speciﬁc
transitory stage for host-pathogen balance, and this scenario
has shaped the existing defensin repertoire [2, 5, 6]. To this
end, the understanding of the evolutionary forces driving
this molecular process should facilitate the design of more
eﬀective antibiotics.
Among all these antimicrobial peptides, human
β-defensin 3 (DEFB103A) has received the most interest for
possible pharmaceutical applications [7, 8]. This protein
exhibits not only a broad-spectrum antibacterial eﬀect
[9] but also other important biological functions such
as chemoattraction of immune cells [7] and initiation of
remodeling processes in articular cartilage [10]. To identify
and functionally characterize the role of DEFB103A peptide
in host-microbe interactions, the putative homologous
protein, the mouse β-defensin 14 (DEFB14) has been
selectedasaprototypicalmodel[11–13].HumanDEFB103A
and mouse DEFB14 carry the highest number of cationic
charges (+11 and +12, resp.) of all β-defensins (BDEFs) [11].
The DEFB14 gene is constitutively expressed in epithelial
c e l l so fe y e ,t o n g u e ,t r a c h e a ,e s o p h a g u s ,t h y m u s ,l u n g ,l i v e r ,
small intestine, spleen, testis, epididymis, and dendritic cells
[11, 12].
The present report reveals the precise orthologous rela-
tionshipbetweenβ-defensin3andhomologouspeptidesand2 Comparative and Functional Genomics
provides new insights into the protein niche specialization
of these antimicrobial proteins. These ﬁndings provide
important molecular bases for the design of more eﬀective
antibiotics.
2.MaterialsandMethods
2.1. Identiﬁcation and Analysis of β-Defensin 3 Ortholo-
gous Groups. The widely used approach of reciprocal (bi-
directional) best hits (RBH) [14, 15] was implemented for
constructing related orthologous groups of DEFB103A and
DEFB14 across multiple eukaryotic taxa. BLASTP analysis
[16] was used to back-search amino acid sequences against
well-annotated and -curated protein sequences from the
RefSeq database (NCBI Reference Sequence Project). Protein
sequences from this orthologous group were aligned using
the M-Coﬀee software, a metamethod for assembling multi-
ple sequence alignments [17]. Jalview software analysis [18]
was used to estimate degree of conservation and consensus
between all protein sequences. Then, the protein alignments
were used for phylogenetic tree reconstruction using the
maximum parsimony method [19] with the PAUP
∗ 4.0 b10
program[20].Thestatisticalsigniﬁcanceofbranchorderwas
estimated by the generation of 1000 replications of bootstrap
resampling of the originally-aligned amino acid sequences.
2.2. Evolution of β-Defensin 3 in the Eutheria–Metatheria
Clade. Because the identiﬁcation of domains that occur
within proteins can provide insights into their function
[21, 22], the identiﬁcation of conserved domains in protein
sequences of the Eutheria–Metatheria BDEF3 (hereafter
mammalian BDEF3) clade was analyzed. Pfam algorithm
[23,24] wasused for theidentiﬁcation of conserved domains
within the predicted mammalian BDEF3 orthologous group.
Protein sequences of the mammalian BDEF3 orthologous
group were aligned using the M-Coﬀee software and
phylogenetic tree reconstruction by means of maximum
parsimony was performed as described above.
2.3. Assessment of Protein Niche Specialization in the Mam-
malian BDEF3 Clade. To examine the likelihood of pro-
tein niche specialization in the mammalian BDEF3 clade,
homologous proteins were aligned using the M-Coﬀee
software and Jalview was used to identify the twenty-three
residues, FLPKTLRKFFCRIRGGRCAVLNC, responsible for
the antimicrobial activity [7, 8, 11]. This antimicrobial-
domain was retrieved from each mature peptide region of
proteins included in the mammalian BDEF3 orthologous
group, and divergence of amino acid residues was analyzed
by generating sequence logos [25]. To conﬁrm the speciﬁcity
of this antimicrobial-domain among the mammalian BDEF3
lineage, RBH was performed to identify other peptides
containing this domain. BLASTP analysis was used to back-
search amino acid sequences against the RefSeq database.
In addition, site-speciﬁc synonymous and nonsynonymous
substitution rate was estimated by maximum likelihood-
based methods [26] for identiﬁcation of residues subject to
positive selection.
3. Results
3.1. Identiﬁcation and Analysis of β-Defensin 3 Orthologous
Group. Fifty-six BDEF protein sequences were obtained in
the construction of DEFB103A and DEFB14 orthologous
groups. This dataset enclosed protein sequences of BD1,
-2, -3, and -4 across diﬀerent taxa (Figure 1). Phylogenetic
analysis using the maximum parsimony identiﬁed seven
major BDEF clades: (I) rat-mouse BDEF38, (II) Eutheria–
Metatheria BDEF3, (III) horse BDEF, (IV) cow BDEF, (V)
primateBDEF4,(VI)rat-mouseBDEF4and(VII)rat-mouse
BDEF2 (Figure 1). Moreover, alignment and analysis of the
BDEF proteins conﬁrmed the conservation of the canonical
six-cysteinemotifintheBDEForthologousgroup(Figure 2).
3.2. Evolution of β-Defensin 3 in the Eutheria–Metatheria
Clade. To gain some insights into protein function of the
mammalian BDEF3, the identiﬁcation of conserved domains
was performed with the Pfam algorithm [23, 24]. All
proteins enclosed in the mammalian BDEF3 clade contained
the structural components of the β-defensin domain (data
not shown). Moreover, phylogenetic analysis revealed that
proteinsimilarityisgreateramongcloselyrelatedspeciesand
identiﬁedprimate-,ungulate-,cow-,androdent-BDEF3pro-
tein clusters (Figure 3). Interestingly, when cationic charges
were estimated for each amino acid sequence, it was found
that charges are similar within proteins of the primate-,
ungulate-, cow-, and rodent-BDEF3 clusters (+12.2, +12 and
+11, +10.7, +12; resp.).
3.3. Assessment of Protein Niche Specialization in the Mam-
malian BDEF3 Clade. To gain some insights into the
molecular basis for protein niche specialization of mam-
malian BDEF3, antimicrobial-domains were retrieved from
each mature peptide region of proteins included in the
mammalian BDEF3 orthologous group (Figure 4). Then,
sequence logos were generated for each antimicrobial-
domain identiﬁed (Figure 5). These analyses demonstrate
that eleven out of twenty-three residues in the antimicrobial-
domain are highly variable across the mammalian BDEF3
clade (Figures 4 and 5). Moreover, primate-, ungulate-,
cow-, and rodent-BDEF3 clusters show diﬀerent amino acid
residue variation (Figure 5). To conﬁrm the speciﬁcity of
this antimicrobial-domain among the mammalian lineage,
the amino acid residues contained in the antimicrobial
domain were subject to RBH analysis with BLASTP algo-
rithm against the RefSeq database. This analysis conﬁrmed
that this antimicrobial domain is a particular attribute
of the mammalian BDEF3 clade. This unusual pattern is
evidence of natural selection acting on the diversiﬁcation
of BDEFs and supports the idea of mammalian BDEF3
niche specialization. To conﬁrm this notion, site-speciﬁc
synonymous and nonsynonymous substitution rates were
estimated by maximum likelihood-based methods [26]f o r
the identiﬁcation of residues subject to positive selection.
This analysis demonstrates that eleven amino acid residues
of the antimicrobial domain have been mutated by positive
selection to confer BDEF3 niche specialization (Figure 5).Comparative and Functional Genomics 3
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Figure 1: Phylogenetic tree of β-defensin orthologous groups. Maximum parsimony tree with bootstrap conﬁdence levels based on protein
sequences from the animal kingdom. Protein identiﬁcations correspond to β-defensin (BD) type, species, and accession number as reported
by the RefSeq database. Seven major β-defensin clades are indentiﬁed: (I) rat-mouse BDEF38, (II) Eutheria–Metatheria BDEF3, (III) horse
BDEF, (IV) cow BDEF, (V) primate BDEF4, (VI) rat-mouse BDEF4 and (VII) rat-mouse BDEF2. These results indicate that β-defensin has
undergone niche specialization.4 Comparative and Functional Genomics
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Figure 2: Conservation of the canonical six-cysteine motif in β-defensin orthologous groups. Multiple sequence alignment of complete
β-defensin amino acid sequences was performed. Conserved cysteines in the mature peptide region are highlighted in red. Aligned residue
position is indicated above the sequence. Only a fragment of the mature peptide region is shown.Comparative and Functional Genomics 5
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Figure 3: Phylogenetic tree of mammalian BDEF3 orthologous group. Maximum parsimony tree with bootstrap conﬁdence levels based on
protein sequences of mammals. Primate-, ungulate-, cow-, and rodent-BDEF3 clusters were identiﬁed. Protein charges are similar within
sequences of each BDEF3 cluster (+12.2, +12 and +11, +10.7, +12, resp.). These results demonstrate that mammalian BDEF3 undergoes
niche specialization during protein evolution.
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Figure 4: Mammalian speciﬁc antimicrobial domain. Proteins were aligned and the twenty-three residue antimicrobial-domain was
localized (boxed sequence, top alignment) and retrieved (bottom alignment) from each mature peptide. These data reveals the divergence of
amino acid residue in β-defensin 3 and homologous peptides.6 Comparative and Functional Genomics
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Figure 5: Sequence logos generated for each antimicrobial-domain showing the divergence of amino acid residue in β-defensin 3 and
homologous peptides. Red arrows show amino acids subject to positive selection. Primate-, ungulate-, cow-, and rodent-BDEF3 clusters
have diﬀerent amino acid residue variations. This analysis demonstrates that eleven amino acid residues of the antimicrobial domain have
been mutated by positive selection to confer BDEF3 niche specialization.
4. Discussion
In an eﬀort to improve our understanding of the molecular
basis regarding the mechanism of action of BDEF and
facilitatethedesignnewtherapeuticagents,thepresentstudy
examinestheevolutionofβ-defensin3anditsantimicrobial-
domain. Herein, the phylogenetic analysis of the BDEF pro-
tein family across multiple species provides deﬁnite evidence
of true orthology between human DEFB103A and mouse
DEFB14. Moreover, it is revealed that positive selection has
acted to diversify defensins and that mammalian BDEF3
undergoes niche specialization during protein evolution.
The nomenclature of BDEF proteins is complicated.
Defensins have been annotated sequentially on discovery,
and in some instances, orthologous proteins receive the
same number [27]. However, there are cases such as human
DEFB103A and mouse DEFB14, in which orthologous rela-
tionships are not so obvious. In the present study, the phy-
logenetic analysis of the BDEF protein family across multiple
species identiﬁed seven major BDEF clades and established
orthologous relationships among these proteins. For exam-
ple, the Eutheria–Metatheria clade is comprised by human,
chimp, and cow DEFB103A; mouse and rat DEFB14; and
cow, horse, and pig BDEF3 proteins. Moreover, the phylo-
genetic analysis conﬁrmed the conservation of the canonical
cysteine motif (X2-10CX5-6G/AXCX3-4CX9-13CX4-7CCXn)i n
the defensin family [27]. Disulphide bridges generated
between these conserved cysteines confer more resistance
to bacterial proteolysis, even though the disulphide bridges
are not essential for the antimicrobial activity [2, 7, 28, 29].
These results demonstrate that β-defensins likely evolved to
encode similar functions among eukaryotic taxa but these
protein sequences have undergone niche specialization.
In the present study, protein niche specialization of
mammalian BDEF3 is supported by at least three molec-
ular bases. First, phylogenetic analysis of proteins from
mammalian BDEF3 clade identiﬁed primate-, ungulate-,
cow-, and rodent- protein clusters within the mammalian
BDEF3 clade. It was also found that proteins of each BDEF3
cluster have similar cationic charges. Second, analysis of
amino acid residues of the antimicrobial-domain [7, 8, 11]
revealed that this protein domain is a particular attribute
of the mammalian BDEF3 clade. Third, it was found that
eleven out of twenty-three residues in the antimicrobial-
domain are highly variable across the mammalian BDEF3
clade and that these amino acids have been mutated by
positive selection to confer BDEF3 niche specialization. A
similar evolutionary scenario was determined for clusters of
mammalian α-defensins [30] and other β-defensins [31, 32].
It can be hypothesized that the selection pressures on
the evolution of defensins might have occurred to preserve
an adaptive phenotype, increase functional divergence, andComparative and Functional Genomics 7
enhance microbe killing eﬃciency [27, 31]. In fact, it was
demonstrated that amino acid substitutions at sites subject
to positive selection increase the antimicrobial activity of
BDEFs against bacterial pathogens [33]. Accordingly, it was
suggested that positive selection at particular residues is
involved in directing a new antimicrobial response against
speciﬁc pathogens [33]. The value of these observations for
biomedical research is also established by the elegant study
by Antcheva et al. [34]. These authors demonstrated that
the increase in antimicrobial activity of two homologous
β-defensin 2 (human and macaque) is caused by amino acid
residues subject to positive selection [34].
Together, these data are consistent with the notion that
natural selection acts as evolutionary force driving the
proliferation and diversiﬁcation of defensins. Indeed, these
results strongly support the hypothesis that BDEFs niche
specialization is caused by host-pathogen coevolution [2, 31,
35]. Thus, this information has potential for the structure-
guide design of novel antimicrobial peptides.
In summary, this report indicates that the production of
antimicrobial peptides is a response to pathogen diversity
and their coevolution generates niche specialization for
maintaining a host-pathogen balance. These data support
the notion that natural selection acts as evolutionary force
driving the proliferation and diversiﬁcation of defensins and
introduce a novel strategy for the design of more eﬀective
antibiotics.
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